NCT06391580尚未招募不适用
A Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 192
- 试验地点
- 1
- 主要终点
- Efficacy rate of jawline contour deficit improvement in the test group at 48 weeks after the last injection and that in the control group at 48 weeks after randomization, evaluated by blinded evaluators using the MJAS.
研究概览
简要总结
A Multi-center, Randomized, No-treatment Controlled, Evaluator-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects who aged 18 years or older (subject to the date of signing the informed consent), male or female;
- •Subjects with a MJAS score of moderate to severe levels (2~3 scores) in terms of bilateral jawline contour as evaluated by the blinded evaluator, and the scores of bilateral jawline contour must meet the criteria but not required to be the same;
- •Subjects who are seeking to receive corrective treatment for jawline contouring;
- •Subjects who are in good health and suitable to receive corrective treatment for jawline contouring as evaluated by the blinded evaluator;
- •Subjects who voluntarily sign the ICF, understand and accept the study duration, and are able to comply with all requirements including treatment, follow-ups and other study procedures as scheduled;
排除标准
- •Subjects with non-aging skin laxity and lipoatrophy which may affect the evaluation of efficacy in the midface or mandibular region as identified by the investigator;
- •Subjects who are known to be allergic to any local anesthetics (such as lidocaine or other amide anesthetics), or have a history of severe allergic reactions or anaphylactic shock;
- •Subjects who have residual defects, scars, deformities, tattoos, perforations, hair, unhealed wounds, active skin diseases or inflammations (such as eczema, acnes, psoriasis, and herpes zoster), abscesses, carcinogenesis or precancerous lesions and other conditions that may affect evaluation of vision and efficacy or increase the risk of treatment in the injection and evaluation areas;
- •Subjects with unstable and/or irreproducible malocclusion, or bruxism, hypertrophy or asymmetry of masseter, lockjaw, active temporomandibular disorders or active periodontal diseases;
- •Subjects who have a tendency to develop keloids, hypertrophic scars, or any other healing disorders.
结局指标
主要结局
Efficacy rate of jawline contour deficit improvement in the test group at 48 weeks after the last injection and that in the control group at 48 weeks after randomization, evaluated by blinded evaluators using the MJAS.
时间窗: 48 weeks
次要结局
- Efficacy rate of jawline contour deficit improvement (as evaluated by blinded evaluators, except for the primary efficacy index visit point)(5, 12, 24 and 36 weeks)
- Jawline contour deficit improvement score (as evaluated by blinded evaluators)(5, 12, 24, 36 and 48 weeks)
- Change in FACE-QTM Satisfaction with Lower Face and Jawline score from the baseline (as evaluated by the subject)(5, 12, 24 36 and 48 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
A Prospective, Randomized, No-treatment Controlled, Evaluator-blinded Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Microspherical Injectable to Improve Forehead ContourForehead ContouringNCT06380972AQTIS Medical B.V.189
已完成
不适用
Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline ContouringJaw Volume DeficitNCT04886544LG Chem72
已完成
3 期
A multi-center, randomized controlled trial comparing early versus elective colonoscopy in outpatients with acute lower gastrointestinal bleedingAcute lower gastrointestinal bleedingJPRN-UMIN000021129Graduate School of Medicine, The University of Tokyo162
终止
3 期
A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology PatientsACTRN12605000137695Australasian Leukaemia and Lymphoma Group240
已完成
不适用
A multi-center randomized controlled trial Comparing Standard Prednisolone therapy with Standard Prednisolone therapy + High-dose Mizoribine for the Treatment of early-relapsing steroid sensitive nephrotic syndrome in children (JSKDC05)Steroid sensitive nephrotic syndrome in childrenJPRN-UMIN000005103Japanese Study Group of Kidney Disease in Children120